For weight management, the FDA-approved Semaglutide product is Wegovy
The FDA has reported adverse-event concerns involving compounded semaglutide and tirzepatide, including dosing errors, gastrointestinal symptoms, and events that required medical attention
Key Facts About Ozempic Active ingredient: Semaglutide (same as Wegovy) FDA approval: Type 2 diabetes management Dosing schedule: Once weekly Typical dosage for weight loss: Up to 2.0 mg weekly Target patients: Individuals with diabetes or those seeking off-label weight loss Why Is Ozempic Used for Weight Loss
(B) Semaglutide, as a GLP-1 analog, can directly act on fat cells, increase the expression of thermogenic genes for browning phenotype maintenance, improve the expression of uncoupling protein 1 (UCP1), mitochondrial biosynthesis, and thermogenic marker, or promote fatty browning through nitric oxide synthase (NOS), neuropeptides (NPs), sirtuin 1 (STRT1), signal transducer and activator of transcription 3 (STAT3), and bone morphogenetic protein 4 (BMP4) signaling
Also, insurance providers generally do not cover compounded GLP-1 medication
Looking at the data another way, a daily dose of Saxenda was 2.7 times as likely to delay type 2 diabetes as placebo
